OPKO Health (OPK) Tops Q2 EPS by 6c
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.40 --0%
Financial Fact:
Total operating expenses: 321.66M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Total operating expenses: 321.66M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.01), $0.06 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $263.7 million versus the consensus estimate of $261.65 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- OPKO Health raises $125M in notes backed by mazdutide royalties
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
